DOCSLIB.ORG

2958.Full.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2958.Full.Pdf The Orphan Nuclear Receptor NR4A3 Is Involved in the Function of Dendritic Cells Masanori Nagaoka, Takuya Yashiro, Yuna Uchida, Tomoaki Ando, Mutsuko Hara, Hajime Arai, Hideoki Ogawa, Ko This information is current as Okumura, Kazumi Kasakura and Chiharu Nishiyama of September 27, 2021. J Immunol 2017; 199:2958-2967; Prepublished online 11 September 2017; doi: 10.4049/jimmunol.1601911 http://www.jimmunol.org/content/199/8/2958 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2017/09/09/jimmunol.160191 Material 1.DCSupplemental http://www.jimmunol.org/ References This article cites 23 articles, 10 of which you can access for free at: http://www.jimmunol.org/content/199/8/2958.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 27, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2017 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology The Orphan Nuclear Receptor NR4A3 Is Involved in the Function of Dendritic Cells Masanori Nagaoka,*,1 Takuya Yashiro,*,1 Yuna Uchida,* Tomoaki Ando,† Mutsuko Hara,† Hajime Arai,† Hideoki Ogawa,† Ko Okumura,† Kazumi Kasakura,* and Chiharu Nishiyama*,† NR4A3/NOR1 belongs to the NR4A subfamily of the nuclear hormone receptor superfamily, which is activated in a ligand- independent manner. To examine the role of NR4A3 in gene expression of dendritic cells (DCs), we introduced NR4A3 small interfering RNA (siRNA) into bone marrow–derived DCs and determined the expression levels of mRNA and proteins of cytokines, cell surface molecules, NF-kB signaling–related proteins, and transcription factors. The expression level of NR4A3 was markedly upregulated by TLR-mediated stimulation in DCs. NR4A3 knockdown significantly suppressed LPS, CpG, or poly(I:C)- mediated upregulation of CD80, CD86, IL-10, IL-6, and IL-12. Proliferation and IL-2 production levels of T cells cocultured with Downloaded from NR4A3 knocked-down DCs were significantly lower than that of T cells cocultured with control DCs. Furthermore, the expression of IKKb, IRF4, and IRF8 was significantly decreased in NR4A3 siRNA-introduced bone marrow–derived DCs. The knockdown exper- iments using siRNAs for IKKb, IRF4, and/or IRF8 indicated that LPS-induced upregulation of IL-10 and IL-6 was reduced in IKKb knocked-down cells, and that the upregulation of IL-12 was suppressed by the knockdown of IRF4 and IRF8. Taken together, these results indicate that NR4A3 is involved in TLR-mediated activation and gene expression of DCs. The Journal of Immunology, 2017, 199: 2958–2967. http://www.jimmunol.org/ he NR4A subfamily of the nuclear hormone receptor super- orphan receptors, which function as constitutively active (ligand family consists of NR4A3/NOR1 along with NR4A1/Nur77 independent) transcription factors, based on the identified three- T and NR4A2/Nurr1. These molecules are recognized to be dimensional structure of the ligand-binding domain (LBD) of NR4A2 (1). NR4A3 was first focused on in neurons, because NR4A3-deficient mice exhibit defects in the inner ear and in hippocampal devel- *Laboratory of Molecular Biology and Immunology, Department of Biological Science opment (2, 3). In subsequent studies, the role of NR4A3 in athero- and Technology, Faculty of Industrial Science and Technology, Tokyo University of sclerosis has been analyzed, because high expression of NR4A3 by guest on September 27, 2021 Science, Tokyo 125-8585, Japan; and †Atopy (Allergy) Research Center, Juntendo University School of Medicine, Tokyo 113-8421, Japan together with NR4A1 and NR4A2 was detected in atherosclerotic 1M.N. and T.Y. contributed equally to this work. lesions (4). Hematopoietic cell–specific NR4A3 knockout (KO) ac- ORCID: 0000-0002-8548-4424 (T.A.). celerates atherosclerosis with monocytosis (5), whereas full NR4A3 KO mice show decreased atherosclerosis (6), suggesting that NR4A3 Received for publication November 9, 2016. Accepted for publication August 12, 2017. possesses hematopoietic cell–specific functions, especially those that This work was supported by the Funding Program for Next Generation World-Leading are monocyte lineage–specific, although NR4A3 is expressed in Researchers through Ministry of Education, Culture, Sports, Science and Technology various cell types including smooth muscle cells and neuronal of Japan (MEXT) Grant LS111 (to C.N.), the MEXT-Supported Program for the cells. A recent study investigating NR4A in acquired immunity Strategic Research Foundation at Private Universities (Translational Research Center, Tokyo University of Science), and the Tokyo Biochemical Research Foundation. T.Y. showed that triple KO mice lacking all NR4A members do not has been supported by Research Fellowship 10792 (2012–2014) from the Japanese produce regulatory T cells, and develop systemic autoimmunity Society for the Promotion of Science for Young Scientists. K.K. is supported by postdoctoral fellowships (2014–2015) from the Tokyo University of Science and (7). In this study, it was revealed that NR4A is involved in regulatory Research Fellowship 3241 (2016) from the Japanese Society for the Promotion of T cell development by directly transactivating the Foxp3 promoter. Science for Young Scientists. However, the role of NR4A3 in the development and function of a The microarray data presented in this article have been submitted to the Gene Expression typical professional Ag-presenting cell, the dendritic cell (DC), is Omnibus (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE101831) under accession number GSE101831. largely unknown, even though several studies indicated that NR4A3 plays critical roles in the development and inflammatory response of M.N. performed experiments and analyzed data; T.Y. designed research, performed experiments, analyzed data, and wrote the paper; Y.U. performed experiments and monocyte/macrophage lineages (5, 8, 9). In the current study, we analyzed data; T.A. analyzed data and wrote the paper; M.H. performed experiments analyzed the involvement of NR4A3 in the specific gene expression and analyzed data; H.A., H.O., and K.O. provided experimental tools; K.K. per- formed experiments; and C.N. designed research and wrote the paper. and maturation of DCs. Address correspondence and reprint requests to Prof. Chiharu Nishiyama, Laboratory of Molecular Biology and Immunology, Department of Biological Science and Tech- Materials and Methods nology, Faculty of Industrial Science and Technology, Tokyo University of Science, Mice and cells 6-3-1 Niijuku, Katsushika-ku, Tokyo 125-8585, Japan. E-mail address: chinishi@rs. tus.ac.jp BALB/c and C57BL/6 mice were purchased from Japan SLC (Hamamatsu, The online version of this article contains supplemental material. Japan), and OT-II mice were from the Jackson Laboratory (Bar Harbor, Abbreviations used in this article: BM, bone marrow; BMDC, bone marrow–derived ME). Bone marrow–derived DCs (BMDCs), splenic DCs, and BM-derived DC; DC, dendritic cell; KO, knockout; LBD, ligand-binding domain; siRNA, small macrophages were prepared as previously described (10–12). BMDCs interfering RNA; UTR, untranslated region. from C57BL/6 mice were used for a syngeneic T cell proliferation assay, and other experiments were performed with BALB/c cells. All animal Copyright Ó 2017 by The American Association of Immunologists, Inc. 0022-1767/17/$35.00 experiments were performed according to the approved guidelines of the www.jimmunol.org/cgi/doi/10.4049/jimmunol.1601911 The Journal of Immunology 2959 Institutional Review Board of Tokyo University of Science, and this study anti-CD80 Ab (16-10A1; TONBO Biosciences, San Diego, CA) and PE- was specifically approved by the Animal Care and Use Committee of Tokyo conjugated anti-CD86 Ab (GL-1, TONBO). University of Science. Western blot analysis Knockdown experiments using small interfering RNA Western blotting was performed as described previously (11). Abs used in NR4A3 small interfering RNA (siRNA) [Stealth Select RNAi, MSS207089 (#1), this study are as follows: anti-NR4A3 (ab94507; Abcam), anti–IKK-b and MSS207090 (#2)], IRF4 siRNA (MSS205501), IRF8 siRNA (MSS236847), (D30C6), anti-phosphorylated IKK a/b (16A6), anti-IkBa (L35A5), anti- IKKb siRNA (MSS205392), NR4A1 siRNA (MSS205160), NR4A2 siRNA phosphorylated IkBa (14D4), anti-p65 (D14E12), anti-phosphorylated p65 (MSS276105), and control siRNA (Stealth siRNA negative control) were pur- (93H1; all from Cell Signaling Technology, Danvers, MA), anti-IRF4 (sc-6059; chased from Invitrogen (Carlsbad, CA). NR4A3 siRNA targeting the 39- Santa Cruz Biotechnology), anti-IRF8 (sc-6058; Santa Cruz Biotechnology), untranslated region (UTR) used for the NR4A3 coexpression experiment was anti-Flag (F1804; Sigma-Aldrich, St. Louis, MO), anti-hemagglutinin (S1827; synthesized using a custom service as follows: NM_015743.3_stealth_3911, Clontech), and anti–b-actin
Load more

Recommended publications
  • A Molecular Switch from STAT2-IRF9 to ISGF3 Underlies Interferon-Induced Gene Transcription
    ARTICLE https://doi.org/10.1038/s41467-019-10970-y OPEN A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription Ekaterini Platanitis 1, Duygu Demiroz1,5, Anja Schneller1,5, Katrin Fischer1, Christophe Capelle1, Markus Hartl 1, Thomas Gossenreiter 1, Mathias Müller2, Maria Novatchkova3,4 & Thomas Decker 1 Cells maintain the balance between homeostasis and inflammation by adapting and inte- grating the activity of intracellular signaling cascades, including the JAK-STAT pathway. Our 1234567890():,; understanding of how a tailored switch from homeostasis to a strong receptor-dependent response is coordinated remains limited. Here, we use an integrated transcriptomic and proteomic approach to analyze transcription-factor binding, gene expression and in vivo proximity-dependent labelling of proteins in living cells under homeostatic and interferon (IFN)-induced conditions. We show that interferons (IFN) switch murine macrophages from resting-state to induced gene expression by alternating subunits of transcription factor ISGF3. Whereas preformed STAT2-IRF9 complexes control basal expression of IFN-induced genes (ISG), both type I IFN and IFN-γ cause promoter binding of a complete ISGF3 complex containing STAT1, STAT2 and IRF9. In contrast to the dogmatic view of ISGF3 formation in the cytoplasm, our results suggest a model wherein the assembly of the ISGF3 complex occurs on DNA. 1 Max Perutz Labs (MPL), University of Vienna, Vienna 1030, Austria. 2 Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna 1210, Austria. 3 Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna 1030, Austria. 4 Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna 1030, Austria.
    [Show full text]
  • Partner-Regulated Interaction of IFN Regulatory Factor 8 with Chromatin Visualized in Live Macrophages
    Partner-regulated interaction of IFN regulatory factor 8 with chromatin visualized in live macrophages Leopoldo Laricchia-Robbio*, Tomohiko Tamura*, Tatiana Karpova†, Brian L. Sprague†, James G. McNally†, and Keiko Ozato*‡ *Laboratory of Molecular Growth Regulation, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-2753; and †Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-5055 Edited by Laurie H. Glimcher, Harvard School of Public Health, Boston, MA, and approved August 18, 2005 (received for review May 17, 2005) IFN regulatory factor (IRF) 8 is a transcription factor that directs protein–protein interactions on fluorescence recovery have not macrophage differentiation. By fluorescence recovery after pho- been extensively studied. Moreover, many FRAP studies so far tobleaching, we visualized the movement of IRF8-GFP in differen- reported are qualitative, lacking quantitative insight into the tiating macrophages. Recovery data fitted to mathematical models chromatin-binding events. More recent efforts to fit FRAP data revealed two binding states for IRF8. The majority of IRF8 was to mathematical models begin to provide a clearer knowledge on highly mobile and transiently interacted with chromatin, whereas the property of FRAP mobility (16, 17). a small fraction of IRF8 bound to chromatin more stably. IRF8 IRF8, a member of the IFN regulatory factor (IRF) family, is mutants that did not stimulate macrophage differentiation a key factor that guides the development of macrophages (18). showed a faster recovery, revealing little interaction with chro- We previously established an in vitro model system where matin. A macrophage activation signal by IFN-␥͞LPS led to a global IRF8Ϫ/Ϫ myeloid progenitor cells called Tot2 differentiate into slowdown of IRF8 movement, leading to increased chromatin macrophages upon IRF8 introduction (19).
    [Show full text]
  • An Immunoevasive Strategy Through Clinically-Relevant Pan-Cancer Genomic and Transcriptomic Alterations of JAK-STAT Signaling Components
    bioRxiv preprint doi: https://doi.org/10.1101/576645; this version posted March 14, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. An immunoevasive strategy through clinically-relevant pan-cancer genomic and transcriptomic alterations of JAK-STAT signaling components Wai Hoong Chang1 and Alvina G. Lai1, 1Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford, OX3 7FZ, United Kingdom Since its discovery almost three decades ago, the Janus ki- Although cytokines are responsible for inflammation in nase (JAK)-signal transducer and activator of transcription cancer, spontaneous eradication of tumors by endoge- (STAT) pathway has paved the road for understanding inflam- nous immune processes rarely occurs. Moreover, the matory and immunity processes related to a wide range of hu- dynamic interaction between tumor cells and host immu- man pathologies including cancer. Several studies have demon- nity shields tumors from immunological ablation, which strated the importance of JAK-STAT pathway components in overall limits the efficacy of immunotherapy in the clinic. regulating tumor initiation and metastatic progression, yet, the extent of how genetic alterations influence patient outcome is far from being understood. Focusing on 133 genes involved in Cytokines can be pro- or anti-inflammatory and are inter- JAK-STAT signaling, we found that copy number alterations dependent on each other’s function to maintain immune underpin transcriptional dysregulation that differs within and homeostasis(3).
    [Show full text]
  • Transcription Factor IRF8 Directs a Silencing Programme for TH17 Cell Differentiation
    ARTICLE Received 17 Aug 2010 | Accepted 13 Apr 2011 | Published 17 May 2011 DOI: 10.1038/ncomms1311 Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation Xinshou Ouyang1, Ruihua Zhang1, Jianjun Yang1, Qingshan Li1, Lihui Qin2, Chen Zhu3, Jianguo Liu4, Huan Ning4, Min Sun Shin5, Monica Gupta6, Chen-Feng Qi5, John Cijiang He1, Sergio A. Lira1, Herbert C. Morse III5, Keiko Ozato6, Lloyd Mayer1 & Huabao Xiong1 TH17 cells are recognized as a unique subset of T helper cells that have critical roles in the pathogenesis of autoimmunity and tissue inflammation. Although OR Rγt is necessary for the generation of TH17 cells, the molecular mechanisms underlying the functional diversity of TH17 cells are not fully understood. Here we show that a member of interferon regulatory factor (IRF) family of transcription factors, IRF8, has a critical role in silencing TH17-cell differentiation. Mice with a conventional knockout, as well as a T cell-specific deletion, of the Irf8 gene exhibited more efficient TH17 cells. Indeed, studies of an experimental model of colitis showed that IRF8 deficiency resulted in more severe inflammation with an enhanced TH17 phenotype. IRF8 was induced steadily and inhibited TH17-cell differentiation during TH17 lineage commitment at least in part through its physical interaction with RORγt. These findings define IRF8 as a novel intrinsic transcriptional inhibitor of TH17-cell differentiation. 1 Immunology Institute, Department of Medicine, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, New York, New York 10029, USA. 2 Department of Pathology, Mount Sinai School of Medicine, New York, New York 10029, USA.
    [Show full text]
  • Vs. BCR-ABL-Positive Cells to Interferon Alpha
    Schubert et al. Journal of Hematology & Oncology (2019) 12:36 https://doi.org/10.1186/s13045-019-0722-9 RESEARCH Open Access Differential roles of STAT1 and STAT2 in the sensitivity of JAK2V617F- vs. BCR-ABL- positive cells to interferon alpha Claudia Schubert1, Manuel Allhoff2, Stefan Tillmann1, Tiago Maié2, Ivan G. Costa2, Daniel B. Lipka3, Mirle Schemionek1, Kristina Feldberg1, Julian Baumeister1, Tim H. Brümmendorf1, Nicolas Chatain1† and Steffen Koschmieder1*† Abstract Background: Interferon alpha (IFNa) monotherapy is recommended as the standard therapy in polycythemia vera (PV) but not in chronic myeloid leukemia (CML). Here, we investigated the mechanisms of IFNa efficacy in JAK2V617F- vs. BCR-ABL-positive cells. Methods: Gene expression microarrays and RT-qPCR of PV vs. CML patient PBMCs and CD34+ cells and of the murine cell line 32D expressing JAK2V617F or BCR-ABL were used to analyze and compare interferon-stimulated gene (ISG) expression. Furthermore, using CRISPR/Cas9n technology, targeted disruption of STAT1 or STAT2, respectively, was performed in 32D-BCR-ABL and 32D-JAK2V617F cells to evaluate the role of these transcription factors for IFNa efficacy. The knockout cell lines were reconstituted with STAT1, STAT2, STAT1Y701F, or STAT2Y689F to analyze the importance of wild-type and phosphomutant STATs for the IFNa response. ChIP-seq and ChIP were performed to correlate histone marks with ISG expression. Results: Microarray analysis and RT-qPCR revealed significant upregulation of ISGs in 32D-JAK2V617F but downregulation in 32D-BCR-ABL cells, and these effects were reversed by tyrosine kinase inhibitor (TKI) treatment. Similar expression patterns were confirmed in human cell lines, primary PV and CML patient PBMCs and CD34+ cells, demonstrating that these effects are operational in patients.
    [Show full text]
  • A Dual Cis-Regulatory Code Links IRF8 to Constitutive and Inducible Gene Expression in Macrophages
    Downloaded from genesdev.cshlp.org on October 1, 2021 - Published by Cold Spring Harbor Laboratory Press A dual cis-regulatory code links IRF8 to constitutive and inducible gene expression in macrophages Alessandra Mancino,1,3 Alberto Termanini,1,3 Iros Barozzi,1 Serena Ghisletti,1 Renato Ostuni,1 Elena Prosperini,1 Keiko Ozato,2 and Gioacchino Natoli1 1Department of Experimental Oncology, European Institute of Oncology (IEO), 20139 Milan, Italy; 2Laboratory of Molecular Growth Regulation, Genomics of Differentiation Program, National Institute of Child Health and Human Development (NICHD), National Institutes of Health, Bethesda, Maryland 20892, USA The transcription factor (TF) interferon regulatory factor 8 (IRF8) controls both developmental and inflammatory stimulus-inducible genes in macrophages, but the mechanisms underlying these two different functions are largely unknown. One possibility is that these different roles are linked to the ability of IRF8 to bind alternative DNA sequences. We found that IRF8 is recruited to distinct sets of DNA consensus sequences before and after lipopolysaccharide (LPS) stimulation. In resting cells, IRF8 was mainly bound to composite sites together with the master regulator of myeloid development PU.1. Basal IRF8–PU.1 binding maintained the expression of a broad panel of genes essential for macrophage functions (such as microbial recognition and response to purines) and contributed to basal expression of many LPS-inducible genes. After LPS stimulation, increased expression of IRF8, other IRFs, and AP-1 family TFs enabled IRF8 binding to thousands of additional regions containing low-affinity multimerized IRF sites and composite IRF–AP-1 sites, which were not premarked by PU.1 and did not contribute to the basal IRF8 cistrome.
    [Show full text]
  • PU.1 Cooperates with IRF4 and IRF8 to Suppress Pre-B-Cell Leukemia
    Leukemia (2016) 30, 1375–1387 © 2016 Macmillan Publishers Limited All rights reserved 0887-6924/16 www.nature.com/leu ORIGINAL ARTICLE PU.1 cooperates with IRF4 and IRF8 to suppress pre-B-cell leukemia SHM Pang1,2, M Minnich3, P Gangatirkar1,2, Z Zheng1, A Ebert3, G Song4, RA Dickins1,2,5, LM Corcoran1,2, CG Mullighan4, M Busslinger3, ND Huntington1,2, SL Nutt1,2 and S Carotta1,2,6 The Ets family transcription factor PU.1 and the interferon regulatory factor (IRF)4 and IRF8 regulate gene expression by binding to composite DNA sequences known as Ets/interferon consensus elements. Although all three factors are expressed from the onset of B-cell development, single deficiency of these factors in B-cell progenitors only mildly impacts on bone marrow B lymphopoiesis. Here we tested whether PU.1 cooperates with IRF factors in regulating early B-cell development. Lack of PU.1 and IRF4 resulted in a partial block in development the pre-B-cell stage. The combined deletion of PU.1 and IRF8 reduced recirculating B-cell numbers. Strikingly, all PU.1/IRF4 and ~ 50% of PU.1/IRF8 double deficient mice developed pre-B-cell acute lymphoblastic leukemia (B-ALL) associated with reduced expression of the established B-lineage tumor suppressor genes, Ikaros and Spi-B. These genes are directly regulated by PU.1/IRF4/IRF8, and restoration of Ikaros or Spi-B expression inhibited leukemic cell growth. In summary, we demonstrate that PU.1, IRF4 and IRF8 cooperate to regulate early B-cell development and to prevent pre-B-ALL formation.
    [Show full text]
  • Differential Expression of IFN Regulatory Factor 4 Gene in Human Monocyte-Derived Dendritic Cells and Macrophages
    Differential Expression of IFN Regulatory Factor 4 Gene in Human Monocyte-Derived Dendritic Cells and Macrophages This information is current as Anne Lehtonen, Ville Veckman, Tuomas Nikula, Riitta of September 27, 2021. Lahesmaa, Leena Kinnunen, Sampsa Matikainen and Ilkka Julkunen J Immunol 2005; 175:6570-6579; ; doi: 10.4049/jimmunol.175.10.6570 http://www.jimmunol.org/content/175/10/6570 Downloaded from References This article cites 79 articles, 45 of which you can access for free at: http://www.jimmunol.org/content/175/10/6570.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 27, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2005 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Differential Expression of IFN Regulatory Factor 4 Gene in Human Monocyte-Derived Dendritic Cells and Macrophages1 Anne Lehtonen,2* Ville Veckman,* Tuomas Nikula,‡ Riitta Lahesmaa,‡ Leena Kinnunen,† Sampsa Matikainen,* and Ilkka Julkunen* In vitro human monocyte differentiation to macrophages or dendritic cells (DCs) is driven by GM-CSF or GM-CSF and IL-4, respectively.
    [Show full text]
  • Deletion of Irf4 in T Cells Suppressed Autoimmune Uveitis and Dysregulated Transcriptional Programs Linked to CD4+ T Cell Differentiation and Metabolism
    International Journal of Molecular Sciences Article Deletion of Irf4 in T Cells Suppressed Autoimmune Uveitis and Dysregulated Transcriptional Programs Linked to CD4+ T Cell Differentiation and Metabolism Minkyung Kang 1,†, Hyun-Su Lee 1,†, Jin Kyeong Choi 1,2, Cheng-Rong Yu 1 and Charles E. Egwuagu 1,* 1 Molecular Immunology Section, Laboratory of Immunology, National Eye Institute (NEI), National Institute of Health, Bethesda, MD 20892, USA; [email protected] (M.K.); [email protected] (H.-S.L.); [email protected] (J.K.C.); [email protected] (C.-R.Y.) 2 Department of Immunology, Jeonbuk National University Medical School, Jeonju, Jeonbuk 54907, Korea * Correspondence: [email protected]; Tel.: +301-496-0049; Fax: +301-480-3914 † These authors contributed equally. Abstract: Interferon regulatory factor-4 (IRF4) and IRF8 regulate differentiation, growth and functions of lymphoid and myeloid cells. Targeted deletion of irf8 in T cells (CD4-IRF8KO) has been shown to exacerbate colitis and experimental autoimmune uveitis (EAU), a mouse model of human uveitis. We therefore generated mice lacking irf4 in T cells (CD4-IRF4KO) and investigated whether expression of IRF4 by T cells is also required for regulating T cells that suppress autoimmune diseases. Surprisingly, we found that CD4-IRF4KO mice are resistant to EAU. Suppression of EAU derived in part from inhibiting pathogenic responses of Th17 cells while inducing expansion of regulatory lymphocytes that secrete IL-10 and/or IL-35 in the eye and peripheral lymphoid tissues. Furthermore, CD4- IRF4KO T cells exhibit alterations in cell metabolism and are defective in the expression of two Citation: Kang, M.; Lee, H.-S.; Choi, Ikaros zinc-finger (IKZF) transcription factors (Ikaros, Aiolos) that are required for lymphocyte J.K.; Yu, C.-R.; Egwuagu, C.E.
    [Show full text]
  • Estrogen Receptor-Dependent Regulation of Dendritic Cell Development and Function
    REVIEW published: 10 February 2017 doi: 10.3389/fimmu.2017.00108 Estrogen Receptor-Dependent Regulation of Dendritic Cell Development and Function Sophie Laffont1*, Cyril Seillet2,3 and Jean-Charles Guéry1* 1 Centre de Physiopathologie de Toulouse Purpan (CPTP), Université de Toulouse, INSERM, CNRS, UPS, Toulouse, France, 2 Division of Molecular Immunology, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, 3 Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia Autoimmunity, infectious diseases and cancer affect women and men differently. Because they tend to develop more vigorous adaptive immune responses than men, women are less susceptible to some infectious diseases but also at higher risk of autoimmunity. The regulation of immune responses by sex-dependent factors probably involves several non-redundant mechanisms. A privileged area of study, however, concerns the role of sex steroid hormones in the biology of innate immune cells, especially dendritic cells (DCs). In recent years, our understanding of the lineage origin of DC populations has expanded, Edited by: and the lineage-committing transcription factors shaping peripheral DC subsets have Manfred B. Lutz, been identified. Both progenitor cells and mature DC subsets express estrogen receptors University of Würzburg, Germany (ERs), which are ligand-dependent transcription factors. This suggests that estrogens Reviewed by: may contribute to the reported sex differences in immunity by regulating DC biology. Meredith O’Keeffe, Monash University, Australia Here, we review the recent literature and highlight evidence that estrogen-dependent Pieter J. M. Leenen, activation of ERα regulates the development or the functional responses of particular DC Erasmus University Rotterdam, + Netherlands subsets.
    [Show full text]
  • Stromal Cell Signature Associated with Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    cells Article Stromal Cell Signature Associated with Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer 1, 2, 3 Maria Lucia Hirata Katayama y, René Aloísio da Costa Vieira y, Victor Piana Andrade , Rosimeire Aparecida Roela 1, Luiz Guilherme Cernaglia Aureliano Lima 3, Ligia Maria Kerr 4, Adriano Polpo de Campos 5,6, Carlos Alberto de Bragança Pereira 7, Pedro Adolpho de Menezes Pacheco Serio 1, Giselly Encinas 1, Simone Maistro 1, Matheus de Almeida Leite Petroni 1, Maria Mitzi Brentani 1 and Maria Aparecida Azevedo Koike Folgueira 1,* 1 Departamento de Radiologia e Oncologia, Centro de Investigação Translacional em Oncologia, Instituto do Cancer do Estado de Sao Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo 01246-000, SP, Brazil; [email protected] (M.L.H.K.); [email protected] (R.A.R.); [email protected] (P.A.d.M.P.S.); [email protected] (G.E.); [email protected] (S.M.); [email protected] (M.d.A.L.P.); [email protected] (M.M.B.) 2 Departamento de Mastologia, Hospital de Câncer de Barretos, Barretos 14.784-400, SP, Brazil; [email protected] 3 A.C. Camargo Cancer Center, Sao Paulo 01525-001, SP, Brazil; [email protected] (V.P.A.); [email protected] (L.G.C.A.L.) 4 Departamento de Patologia, Hospital de Câncer de Barretos, Barretos 14.784-400, SP, Brazil; [email protected] 5 Departamento de Estatística, Centro de Ciências Exatas e de Tecnologia, Universidade Federal de São Carlos, Sao Carlos 13565-905, SP, Brazil; [email protected] 6 Department of Mathematics and Statistics, The University of Western Australia, M019, 35 Stirling Highway, 6009 Crawley, WA, Australia 7 Departamento de Estatística, Instituto de Matemática e Estatística, Universidade de São Paulo, São Paulo 05508-090, SP, Brazil; [email protected] * Correspondence: [email protected] These authors participated equally in this work.
    [Show full text]
  • Epigenetic Disruption of Interferon-Γ Response Through Silencing The
    Oncogene (2008) 27, 5267–5276 & 2008 Macmillan Publishers Limited All rights reserved 0950-9232/08 $30.00 www.nature.com/onc ONCOGENOMICS Epigenetic disruption of interferon-c response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas KY Lee1,11, H Geng1,11,KMNg1,JYu2, A van Hasselt3, Y Cao4, Y-X Zeng5, AHY Wong1, X Wang1, J Ying1, G Srivastava6, ML Lung7, L-D Wang8, TT Kwok9, B-Z Levi10, ATC Chan1, JJY Sung2 and Q Tao1 1Cancer Epigenetics Laboratory, State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China; 2Department of Medicine and Therapeutics, Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China; 3Department of Surgery, Chinese University of Hong Kong, Hong Kong, China; 4Hunan Yale (Xiang Ya) School of Medicine, Central South University, Changsha, China; 5State Key Laboratory in Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China; 6Department of Pathology, University of Hong Kong, Hong Kong, China; 7Department of Biology, Hong Kong University of Science and Technology, Hong Kong, China; 8Henan Key Laboratory for Esophageal Cancer, Zhengzhou University College of Medicine and Cancer Research Center of Xinxiang Medical College, Henan, China; 9Department of Biochemistry, Chinese University of Hong Kong, Hong Kong, China and 10Department of Biotechnology and Food Engineering, Technion-Israel Institute of Technology, Haifa, Israel 16q24 is frequently deleted in multiple tumors including frequently silenced by epigenetic mechanism in multiple cancers of nasopharynx, esophagus, breast, prostate and carcinomas.
    [Show full text]